The call for papers deadline for our Special Issue 'In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery' is less than one week away!🚨 We're looking forward to receiving your next paper for this exciting special issue! #OpenAccess https://t.co/JHlPuyQ4pk

Read more about this research in our interview with co-first authors Meri Uusi-Mäkelä and Sanna-Kaisa Emilia Harjula at Tampere University, Finland. https://t.co/trM9SvUcOr

Our immune system uses special structures called inflammasomes to detect and respond to harmful bacteria, including those that cause TB. Uusi-Mäkelä & co use #zebrafish to explore the role of a key inflammasome adaptor protein called ASC/PYCARD. https://t.co/trM9SvUcOr

Two closely related fungi – Cryptococcus deneoformans (Cd) and Cryptococcus neoformans (Cn) – can cause serious infections. Charles-Niño & co explore how Cd and Cn respond to temperature and how they interact with human tissues, including infection. https://t.co/fcK8sHnQLp

Read our interview with Caroline Beltran, who conducted this research while a postdoc in Gerhard Walzl's lab at Stellenbosch University, South Africa. https://t.co/Mh6QBdhEvh

Caroline Beltran & co describe a novel and unbiased 3D imaging approach that visualises how the lung granulomas that are characteristic of TB infection form, evolve & spatially organise. 🐭 🫁 https://t.co/Mg6xQGpjQI #Tuberculosis #Granuloma

Bats can carry deadly viruses without getting sick. Now, Ng @WeiLunNg1 & Wang give a timely & fascinating #DMMPerspective on the possible translation of discoveries from bats to humans, in the context of treating and preventing #infectiousdiseases. 🦇🧫 https://t.co/uu5PreL8Nn

Biological conduction bridges skip a beat ❤️ #preLight (from Theodora Stougiannou) of a study generating stem-cell derived AVN-like pacemaker cells + demonstrating their functionality for biological conduction bridge applications in vivo. @StephIrisPro https://t.co/75nAZ7haoF

The G307D variant of TOM1, an endosomal adaptor protein, is linked to inborn errors of immunity. Ryhänen & co use patient cells to show that this mutation disrupts the interaction of TOM1 with TOLLIP, impairing cargo trafficking & autophagy regulation. https://t.co/kdqqn9yaPg

Read more in our interview with Victor Tapia, a postdoc research associate in Catherine Lawrence's and Paul Kasher's labs at The University of Manchester, UK, investigating the causes and neuroprotective mechanisms of intracerebral haemorrhage. https://t.co/YKi7nnGNyU

Using a zebrafish model & human brain tissue, Tapia & co find that high levels of CH25H and 25HC are linked to small brain bleeds following COVID-19 infection. They show that 25HC can damage endothelial cells, especially when cholesterol levels are low. https://t.co/pYLIfMQ06o

We are delighted to announce the topic for our 2026 Journal Meeting. Save the date and register for abstract updates on 'Innovative Preclinical Models for Pediatric Cancer Research'. https://t.co/3dd3pPprKr #DMM2026cancer

Read our interview with Claudia Charles-Niño, a postdoctoral associate in Luis Martinez's lab at the University of Florida, USA, who focuses on understanding molecular interactions between pathogens and the host. https://t.co/WL6OMJhbAz

Claudia Charles-Niño & co highlight how fungal adaptation to temperature influences disease progression, which is particularly relevant as global temperatures rise. https://t.co/fcK8sHooAX

The call for papers deadline for our Special Issue 'In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery' is less than one week away!🚨 We're looking forward to receiving your next paper for this exciting special issue. #OpenAccess https://t.co/JHlPuyQCeS

Thank you Clare Muir for sharing your experience of fee-free #OA publishing in @DMM_Journal via our #ReadAndPublish agreement @EdUniMainLib @EdUniLibraries @ScienceUoE @SBSatEd Read Clare’s paper: https://t.co/n676H497F8 Is your institution participating? https://t.co/WpJcxTtBmG

Thank you @DMM_Journal and @Co_Biologists for invitation to this 'At a Glance article' on engineered bacteriophages by Kandas Traore in collaboration with Damien Seyer and Agnes Mihajlovski @UniversiteCergy! Thank you to @EutopiaUni for funding @WarwickLifeSci @uniofwarwick.

In this 'At a Glance' article, Kandas Traore & co highlight how engineered #bacteriophages can be tailored to enhance antibacterial therapies and diagnostics and to support innovative biomedical applications beyond antimicrobial resistance challenges. https://t.co/kEvbganVNh

You can read about Godwin's experience of the one-day programme on antimicrobial resistance at the Biologists @ 100 conference here:

Our next extraordinary biologist is Godwin Pius Ohemu, who attended the Biologists @ 100 conference and shared his conference experience in a guest blog. #100biologists